Treatment outcome with a selective RET tyrosine kinase inhibitor selpercatinib in children with multiple endocrine neoplasia type 2 and advanced medullary thyroid carcinoma
Ananth Shankar, Tom Kurzawinski, Emma Ross, Sara Stoneham, Tim Beale, Ian Proctor, Tony Hulse, Kate Simpson, Mark N. Gaze, Elene Cattaneo, Evelien Gevers, Lynley V. Marshall, Johnathan Hubbard, Caroline Brain
Topics & Concepts
MedicineMultiple endocrine neoplasia type 2CalcitoninThyroid carcinomaCarcinoembryonic antigenInternal medicineGastroenterologyContext (archaeology)Medullary thyroid cancerAdverse effectProgressive diseaseOncologyThyroidEndocrinologyDiseaseCancerGermline mutationMutationBiochemistryPaleontologyChemistryBiologyGeneThyroid Cancer Diagnosis and TreatmentNeuroendocrine Tumor Research AdvancesThyroid and Parathyroid Surgery